Central retinal vein occlusion (CRVO) is a common retinal vascular disorder which affect the patient visual ability. Visual prognosis depends on the type of retinal vein occlusion, that can be ischemic or non-ichemic, its severity, degree of retinal ischemia or macular edema and development of complications. The two most frequent complications of CRVO are persistent macular edema and neovascularization. One of the best and effective treatment for macular edema and neovascularisation seems to be intra vitreal anti-VEGF. Case report: We report 3 cases of CRVO with macular edema, treated with 3 intavitreal aflibercept (EYLEA) in 3 months. The Visual acuity (VA) improved on all 3 cases after each injection. This article aims to review the effec...
AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothel...
Miki Hirose, Wataru Matsumiya, Shigeru Honda, Makoto NakamuraDepartment of Surgery, Division of Opht...
Central retinal vein occlusion (CRVO) associates with severe vision outcome and no proven beneficial...
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder which affect the patient...
After diabetic retinopathy, central retinal vein occlusion (CRVO) is the most common visually disabl...
Macular edema along with macular ischemia is responsible for decreased visual acuity in central reti...
Macular edema along with macular ischemia is responsible for decreased visual acuity in central reti...
This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement ...
Central retinal vein occlusion (CRVO) can cause vision loss. The pathogenesis of CRVO involves a thr...
Retinal vein occlusion is the secondleading cause of vision loss due to vascular disease of the reti...
Retinal vein occlusion (RVO) is the second most common cause of visual loss in the Western World. RV...
\ua9 2020, \ua9 2020 Taylor & Francis Group, LLC. Purpose: Central retinal vein occlusion (CRVO)...
Anti-vascular endothelial growth factor therapy has improved the prognosis for patients with central...
<div><p>Background</p><p>Intravitreal agents have replaced observation in macular edema in central (...
Background: Cystoid macular edema (CME), a common complication of branch retinal vein occlusion (BRV...
AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothel...
Miki Hirose, Wataru Matsumiya, Shigeru Honda, Makoto NakamuraDepartment of Surgery, Division of Opht...
Central retinal vein occlusion (CRVO) associates with severe vision outcome and no proven beneficial...
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder which affect the patient...
After diabetic retinopathy, central retinal vein occlusion (CRVO) is the most common visually disabl...
Macular edema along with macular ischemia is responsible for decreased visual acuity in central reti...
Macular edema along with macular ischemia is responsible for decreased visual acuity in central reti...
This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement ...
Central retinal vein occlusion (CRVO) can cause vision loss. The pathogenesis of CRVO involves a thr...
Retinal vein occlusion is the secondleading cause of vision loss due to vascular disease of the reti...
Retinal vein occlusion (RVO) is the second most common cause of visual loss in the Western World. RV...
\ua9 2020, \ua9 2020 Taylor & Francis Group, LLC. Purpose: Central retinal vein occlusion (CRVO)...
Anti-vascular endothelial growth factor therapy has improved the prognosis for patients with central...
<div><p>Background</p><p>Intravitreal agents have replaced observation in macular edema in central (...
Background: Cystoid macular edema (CME), a common complication of branch retinal vein occlusion (BRV...
AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothel...
Miki Hirose, Wataru Matsumiya, Shigeru Honda, Makoto NakamuraDepartment of Surgery, Division of Opht...
Central retinal vein occlusion (CRVO) associates with severe vision outcome and no proven beneficial...